NASDAQ · Biotechnology

NAUT (NAUT) Stock

$1.20 -27.71% NASDAQ: NAUT Healthcare

Valuation

MetricValue
Price$1.20
Market Cap$152.49M
P/E Ratio-5.06
P/B Ratio1.93
P/S Ratio0.00
EPS (TTM)$-0.47
52-Week High$4.31
52-Week Low$0.62
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-37.58%
ROA-30.89%
ROCE-42.68%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.20
Current Ratio13.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-50.0M$-64.0M$-76.0M$-81.0M$-67.0M
Net Profit$-50.0M$-58.0M$-64.0M$-71.0M$-59.0M
EPS$-0.60$-0.46$-0.51$-0.56$-0.47
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$398.0M$350.0M$306.0M$243.0M$191.0M
Total Liabilities$35.0M$35.0M$40.0M$34.0M$34.0M
Cash$186.0M$115.0M$19.0M$28.0M$12.0M
Borrowings$30.0M$30.0M$35.0M$30.0M$30.0M

Latest News

Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 GlobeNewswire · Jul 8, 2026 3 Penny Stocks With Market Caps Over $100M To Watch Simply Wall St. · Jun 3, 2026 3 Promising Penny Stocks With Market Caps Up To $900M Simply Wall St. · May 5, 2026 Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans Simply Wall St. · May 5, 2026 Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... GuruFocus.com · Apr 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-39.0M$-46.0M$-52.0M$-59.0M$-51.0M
Investing Cash Flow$-141.0M$-28.0M$-46.0M$64.0M$34.0M
Financing Cash Flow$335.0M$0$0$0$0
Net Cash Flow$149.0M$-71.0M$-95.0M$8.0M$-15.0M
Free Cash Flow$-42.0M$-48.0M$-54.0M$-61.0M$-52.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-15.93%
Quick Ratio11.85
Interest Coverage—
Return 1Y138.87%
Return 3Y-44.86%
Return 5Y-81.00%

Ownership

Insiders Held33.21%
Institutions Held40.78%
Institutions Float Held61.05%
Institutional HolderSharesReport Date
a16z Capital Management, L.L.C.17,653,9172026-03-31
Perceptive Advisors Llc12,594,2112026-03-31
Cercano Management Llc7,172,9852026-03-31
Vanguard Capital Management LLC2,545,5972026-03-31
Clearstead Advisors, LLC2,329,7842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARCT $6.26 +0.64% -2.93 $177.93M 0.00%
ASMB $26.68 +0.87% -51.53 $424.02M 0.00%
ENTA $12.61 -0.94% -6.04 $366.68M 0.00%
FHTXFoghorn Therapeutics Inc. $5.20 +7.22% -4.15 $305.31M 0.00%
HUMA $0.66 -1.79% -4.19 $110.81M 0.00%

About NAUT

NAUT is led by CEO Sujal Patel, employs 134 people, headquartered in US, publicly traded since 2020.

NAUT stock trades at $1.20 with a market capitalization of $152.49M. The stock is valued at a price-to-earnings (P/E) ratio of -5.06, price-to-book of 1.93, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.62 and $4.31, and currently trades 72.2% below its 52-week high.

On profitability, NAUT generates a return on equity (ROE) of -37.58%, return on capital employed of -42.68%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides